Douglas G McNeel

Title: Inventor Spotlight: Douglas G. McNeel

Introduction

Douglas G. McNeel is a prominent inventor based in Madison, Wisconsin, known for his significant contributions to the field of prostate cancer research. With a total of 16 patents to his name, McNeel's innovative work revolves around the development of diagnostic and therapeutic methods for prostate cancer. His groundbreaking inventions have the potential to revolutionize cancer diagnostics and treatments, improving the lives of many patients.

Latest Patents

Among his latest patents, one focuses on the "Diagnostic evaluation of antibody responses to commonly recognized prostate cancer-associated antigens." This invention comprises a panel of immunoreactive molecules that help identify candidates for prostate cancer examination. The patent outlines methods for detecting antibodies that indicate pre-malignant or malignant prostate conditions, along with the development of kits to facilitate these diagnostic processes.

Another notable patent is centered on "Combinatorial androgen deprivation with an androgen receptor vaccine." This invention reveals methods of treating prostate cancer through a combination of androgen deprivation therapy (ADT) and vaccination against the androgen receptor or its fragments. The techniques detailed in this patent aim to enhance the effectiveness of ADT, potentially inhibiting, delaying, or reducing the growth of prostate cancer and the onset of castration-resistant prostate cancer.

Career Highlights

Throughout his career, Douglas G. McNeel has made substantial contributions at notable institutions such as the Wisconsin Alumni Research Foundation and the University of Washington. His work has been instrumental in advancing the understanding of prostate cancer and developing targeted therapies.

Collaborations

Collaboration has been a crucial aspect of McNeel’s success. He has worked alongside talented individuals in the field, including Brian Olson and William J. Burlingham. These partnerships have fostered innovative ideas and helped propel research initiatives aimed at combating prostate cancer more effectively.

Conclusion

Douglas G. McNeel's innovative spirit and dedication to cancer research have distinguished him as a leading inventor in his field. With a robust portfolio of patents that contribute to the detection and treatment of prostate cancer, McNeel continues to push the boundaries of medical science, offering hope to countless patients diagnosed with this challenging disease. His work exemplifies the vital role of inventors in advancing healthcare and improving lives through innovation.